Actually I think it's quite productive to speculate why Xanadu failed considering it took 2 - 3 years of time from clinicians, patients, and the company as well as a few million dollars at least. Again, if 10mg a day managed to significantly lower intracellular cortisol, judging from effects on ACTH, androstenedione, etc, then why don't we see any differences in cognition?
Even after 2 years, the team still haven't explained why 10mg has failed, and it's because they don't know - which is a bit worrying to anyone invested in the company. 10 mg is supposed to cause at least 50% inhibition of 11BHSD1 and in animal models those amounts of inhibition were adequate, so to me it's troubling that a drug did 'everything it was supposed to do'... except hit all the primary and secondary endpoints.
Again, I'm still holding out on the promise and potential, but let's be honest with ourselves and recognise that the case is still very much open as to whether Xanamem will work.
- Forums
- ASX - By Stock
- ACW
- 11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis
11βHSD1 inhibitor use in human disease- a systematic review and narrative synthesis, page-11
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
-0.001(3.70%) |
Mkt cap ! $76.57M |
Open | High | Low | Value | Volume |
2.7¢ | 2.7¢ | 2.6¢ | $126.8K | 4.741M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 1312856 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 259595 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 1312856 | 0.026 |
43 | 11694134 | 0.025 |
21 | 5175741 | 0.024 |
21 | 5176667 | 0.023 |
15 | 5176717 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 259595 | 2 |
0.028 | 1572867 | 5 |
0.029 | 2222371 | 10 |
0.030 | 2597700 | 7 |
0.031 | 1051771 | 4 |
Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online